Anika Therapeutics (NASDAQ:ANIK), Inc. is a global, fully integrated, and diversified orthobiologics company focused on the development, manufacture, and commercialization of novel therapies for orthopedic and tissue regeneration applications. Founded in 1998 and headquartered in Bedford, Massachusetts, Anika leverages its proprietary hyaluronic acid (HA) platform technology to create products designed to restore mobility, reduce pain and improve overall patient outcomes. The company’s core offerings include viscosupplementation injections for the treatment of osteoarthritis, surgical sealants, and aesthetic dermatology products.
In its viscosupplementation business, Anika markets products such as MONOVISC® and ORTHOVISC® which are used to alleviate knee pain associated with osteoarthritis by supplementing the synovial fluid in the joint. The surgical franchise includes HA-based bioadhesives and hemostats that support tissue repair and wound healing during soft tissue procedures. Additionally, the company has expanded its pipeline to include combination therapies, such as CINGAL®, which integrate HA with corticosteroids to provide both immediate pain relief and long-term joint health benefits.
With a commercial presence in over 25 countries, Anika continues to grow its global footprint through strategic partnerships and direct sales channels across North America, Europe, Latin America and select markets in Asia. The company’s manufacturing facilities in Bedford and Woburn, Massachusetts, are designed for scalable HA production and meet stringent regulatory standards, supporting both clinical development and commercial supply.
Under the leadership of President and CEO Atul Deshpande, Anika is committed to expanding its portfolio through targeted research and development initiatives aimed at next-generation orthobiologic solutions. The company’s strong focus on innovation, combined with an established commercial infrastructure, positions it to address growing demand for minimally invasive treatments in orthopedic, surgical and aesthetic medicine.
